Description
Conference Objectives: Re-Building meaningful connections through practice, advocacy, and research
The COVID-19 pandemic created a multitude of challenges for both our professional and patient community; however, these challenges have also allowed us to identify opportunities for growth and transformation. Always ahead of the curve, APOS was founded on the belief that all individuals benefit from coming together to innovate and advance the field of psychosocial oncology through research, practice, training, and advocacy. This annual meeting seeks to emphasize and celebrate these relationships, coming together to share novel solutions for pushing the boundaries of cancer care delivery and practice. Having been apart since 2020, we miss you and are excited to reunite in person once again!
Hide
Show More...
The COVID-19 pandemic created a multitude of challenges for both our professional and patient community; however, these challenges have also allowed us to identify opportunities for growth and transformation. Always ahead of the curve, APOS was founded on the belief that all individuals benefit from coming together to innovate and advance the field of psychosocial oncology through research, practice, training, and advocacy. This annual meeting seeks to emphasize and celebrate these relationships, coming together to share novel solutions for pushing the boundaries of cancer care delivery and practice. Having been apart since 2020, we miss you and are excited to reunite in person once again!
Screenshots
APOS 2024 FAQ
-
Is APOS 2024 free?
Yes, APOS 2024 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is APOS 2024 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does APOS 2024 cost?
APOS 2024 is free.
-
What is APOS 2024 revenue?
To get estimated revenue of APOS 2024 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Sweden yet.
Ratings History
APOS 2024 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
APOS 2024 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
MaxLove Connect
Love Hope Thrive
|
View
|
View
|
0
|
|
6 months ago | |
eSteth
eSteth
|
View
|
View
|
0
|
|
6 months ago | |
Mutare Text // Alert
|
View
|
View
|
0
|
|
2 months ago | |
My STORI
|
View
|
View
|
0
|
|
5 months ago | |
SBSM
Stay up to date with SBSM!
|
View
|
View
|
0
|
|
2 months ago | |
Cancer Distress Coach
|
View
|
View
|
0
|
|
2 years ago | |
Bracey Performance 2.0
|
View
|
View
|
0
|
|
1 year ago | |
IPOS 2023
|
View
|
View
|
0
|
|
1 year ago | |
TeamBDN Coaching
|
View
|
View
|
0
|
|
1 month ago | |
CarePilot by Mercurial AI
CarePilot by Mercurial AI
|
View
|
View
|
0
|
|
4 months ago |
APOS 2024 Installs
Last 30 days
APOS 2024 Revenue
Last 30 daysAPOS 2024 Revenue and Downloads
Gain valuable insights into APOS 2024 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- THANIGAIVELAN MUTHU
- Languages
- English
- Recent release
- 1.0.5 (10 months ago )
- Released on
- Feb 16, 2024 (10 months ago )
- Also available in
- Italy, Vietnam, United States, Türkiye, Sweden, Saudi Arabia, Russia, Romania, Portugal, Poland, Philippines, Peru, Netherlands, Nigeria, Kuwait, Japan, Argentina, Israel, Ireland, Indonesia, Egypt, Algeria, Dominican Republic, Germany, Colombia, Chile, Switzerland, Canada, Brazil, Azerbaijan, Australia, Austria
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.